Annual ROE
-109.80%
-65.55%-148.14%
31 December 2023
Summary:
Cara Therapeutics annual return on equity is currently -109.80%, with the most recent change of -65.55% (-148.14%) on 31 December 2023. During the last 3 years, it has fallen by -113.66% (-2944.56%). CARA annual ROE is now -2944.56% below its all-time high of 3.86%, reached on 31 December 2020.CARA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-258.41%
-68.89%-36.35%
30 September 2024
Summary:
Cara Therapeutics quarterly return on equity is currently -258.41%, with the most recent change of -68.89% (-36.35%) on 30 September 2024. Over the past year, it has dropped by -172.07% (-199.29%). CARA quarterly ROE is now -794.09% below its all-time high of 37.23%, reached on 30 June 2013.CARA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CARA ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -148.1% | -199.3% |
| 3 y3 years | -2944.6% | -2306.8% |
| 5 y5 years | -63.5% | -272.4% |
CARA ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -2944.6% | at low | -2306.8% | at low |
| 5 y | 5 years | -2944.6% | at low | -2306.8% | at low |
| alltime | all time | -2944.6% | +31.6% | -794.1% | at low |
Cara Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -258.41%(+36.3%) |
| June 2024 | - | -189.52%(+29.3%) |
| Mar 2024 | - | -146.56%(+35.3%) |
| Dec 2023 | -109.80%(+148.1%) | -108.32%(+25.5%) |
| Sept 2023 | - | -86.34%(+22.7%) |
| June 2023 | - | -70.36%(+48.2%) |
| Mar 2023 | - | -47.48%(+8.8%) |
| Dec 2022 | -44.25%(+19.2%) | -43.62%(+1.3%) |
| Sept 2022 | - | -43.05%(+35.8%) |
| June 2022 | - | -31.69%(-26.8%) |
| Mar 2022 | - | -43.29%(+9.4%) |
| Dec 2021 | -37.12%(-1061.7%) | -39.57%(-437.9%) |
| Sept 2021 | - | 11.71%(+166.7%) |
| June 2021 | - | 4.39%(-43.1%) |
| Mar 2021 | - | 7.72%(+58.8%) |
| Dec 2020 | 3.86%(-105.8%) | 4.86%(-108.1%) |
| Sept 2020 | - | -59.86%(-17.1%) |
| June 2020 | - | -72.19%(-1.5%) |
| Mar 2020 | - | -73.29%(+2.8%) |
| Dec 2019 | -66.41%(-1.1%) | -71.27%(+2.7%) |
| Sept 2019 | - | -69.39%(-6.9%) |
| June 2019 | - | -74.50%(+2.1%) |
| Mar 2019 | - | -72.95%(+1.5%) |
| Dec 2018 | -67.16% | -71.84%(+2.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | -70.27%(+2.1%) |
| June 2018 | - | -68.80%(+3.5%) |
| Mar 2018 | - | -66.45%(-14.2%) |
| Dec 2017 | -84.54%(+15.0%) | -77.49%(-15.3%) |
| Sept 2017 | - | -91.53%(-3.3%) |
| June 2017 | - | -94.61%(-9.4%) |
| Mar 2017 | - | -104.45%(+47.7%) |
| Dec 2016 | -73.54%(+133.4%) | -70.70%(+47.7%) |
| Sept 2016 | - | -47.88%(+10.3%) |
| June 2016 | - | -43.39%(+14.2%) |
| Mar 2016 | - | -38.01%(+11.0%) |
| Dec 2015 | -31.51%(-43.9%) | -34.25%(+10.1%) |
| Sept 2015 | - | -31.11%(-23.8%) |
| June 2015 | - | -40.80%(+20.2%) |
| Mar 2015 | - | -33.93%(-6.4%) |
| Dec 2014 | -56.18%(-1.1%) | -36.24%(-4.4%) |
| Sept 2014 | - | -37.89%(-14.9%) |
| June 2014 | - | -44.51%(+117.8%) |
| Mar 2014 | - | -20.44%(-35.3%) |
| Dec 2013 | -56.82%(-61.3%) | -31.58%(-31.0%) |
| Sept 2013 | - | -45.75%(-222.9%) |
| June 2013 | - | 37.23%(-120.5%) |
| Mar 2013 | - | -181.59%(+146.5%) |
| Dec 2012 | -146.81%(-8.6%) | -73.68% |
| Dec 2011 | -160.65% | - |
FAQ
- What is Cara Therapeutics annual return on equity?
- What is the all time high annual ROE for Cara Therapeutics?
- What is Cara Therapeutics annual ROE year-on-year change?
- What is Cara Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Cara Therapeutics?
- What is Cara Therapeutics quarterly ROE year-on-year change?
What is Cara Therapeutics annual return on equity?
The current annual ROE of CARA is -109.80%
What is the all time high annual ROE for Cara Therapeutics?
Cara Therapeutics all-time high annual return on equity is 3.86%
What is Cara Therapeutics annual ROE year-on-year change?
Over the past year, CARA annual return on equity has changed by -65.55% (-148.14%)
What is Cara Therapeutics quarterly return on equity?
The current quarterly ROE of CARA is -258.41%
What is the all time high quarterly ROE for Cara Therapeutics?
Cara Therapeutics all-time high quarterly return on equity is 37.23%
What is Cara Therapeutics quarterly ROE year-on-year change?
Over the past year, CARA quarterly return on equity has changed by -172.07% (-199.29%)